Tel: +44 (0) 1904 406082

“Improving health through diagnostic innovation”

Abingdon Health is a leading manufacturer and developer of lateral flow immunoassay rapid diagnostic test and reader solutions. We offer an impressive suite of services, from assay development through scalable small and high-volume manufacturing to commercialisation. We serve a global customer base from a variety of regulated and non-regulated industry sectors.

Abingdon Health is certified to ISO 9001:2015 and ISO 13485:2016 and is GMP compliant with the U.S. Food and Drug Administration (FDA).

The foundation of everything we do

We support our customers’ ambitions by offering a flexible and value for money service that consistently produces rapid diagnostic devices that are reliable and meet safety and quality demands.

We strongly believe that building robust long-term partnerships with customers and suppliers, investing in excellence in employee training and development and meeting stakeholder expectations builds an environment that assures the production of quality products.

Abingdon Health will continue to innovate and be a knowledge leader in our field and we will strive to bring the many health and economic benefits offered by the advances in lateral flow rapid diagnostics to all parts of the globe.

Our promise to you

We understand our customers and their requirements during the development and manufacture process. As each project progresses along a robust product development pathway and design review process, we will draw on our experience and develop in-line with our ISO certification.  Our transparent and collaborative approach with our customers, ensure we are aligned and informed through every stage of the program to the point of successful delivery of your product.

Our strategic objectives are:

  • To provide best-in-class lateral flow assays and high quality manufacturing service to our customers.
  • To develop and commercialise rapid diagnostics products that will aim to improve the health outcomes of animals, humans and plants.
  • To innovate our assay and reader technology to provide state-of-the-art diagnostic solutions that supports customer and market needs while improving end-user and patent experience.

Learn more about Abingdon Health’s end-to-end services

 

 

 

Abingdon Health is a member of Medilink